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Background: The association between epilepsy and depressive illness has long been established. However, though various
explanations—psychosocial and anatomical—have been proposed findings from studies are inconsistent and often contradictory.
Aims: This study aimed to compare the features of those people with epilepsy seen in a secondary care setting who developed
a depressive illness with those that did not.
Method: Information regarding the patient’s epilepsy, history and presence of depressive illness and perceived social func-
tioning was gathered from case notes, questionnaire and patient interview.
Results: The experience of a depressive episode was associated with the presence of a right sided lesion, attacks occurring
more than once each month, diagnosis made in adulthood and a perceived marked effect of the epilepsy on mobility and social
activity.
Conclusion: These findings are not all consistent with work already carried out in this field. However, they do point to a
multifactorial aetiology of depressive illness in this group as is the case in the general population. Possible explanations for
frequently contradictory findings are discussed.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
An association between epilepsy and depressive ill-
ness has long been recognised (at least since Hip-
pocrates1) though establishing the mechanism behind
this has proved more elusive. Dysphoric symptoms
are common peri-ictally and are usually considered
to share an aetiology with the epileptic attacks. The
cause of an increased incidence of inter-ictal depres-
sive illness is, however, thought to be multifactorial
and more varied. Links with laterality of focus have
not been consistent between studies though there does
seem to be a more specific association with tempo-
ral lobe epilepsy2 and a greater weight of evidence
to suggest a left sided association3–5. Psychosocial
factors are frequently put forward to explain this in-
creased prevalence with Hermann6 describing it as
analogous to the learned helplessness theory of de-
pression by Seligmann7, though the evident excess
in prevalence when compared with other equally
disabling conditions3 would suggest this is not a
Study undertaken at The Department of Neuroscience, York District Hospital.
complete explanation. To add to the already complex
association between epilepsy and mood, it has been
well documented that certain anti-epileptic drugs
(e.g. carbamazepine, vigabatrin and topiramate) have
direct effects on the patient’s mood as well as some
potentially distressing side-effects. It seems most
likely that, as with the population as a whole, there
are several factors that determine the likelihood of an
individual developing a depressive illness.
One complicating factor in many of the studies to
date is that the subjects have been drawn from tertiary
referral centres and thus, can not be said to be repre-
sentative of people with epilepsy as a whole. The pop-
ulation in this study were seen as a secondary service
(under the care of P.C.) and, as well as a full clinical
examination, were investigated with electroencephalo-
gram (EEG) and either computerised tomography (CT
scan) or nuclear magnetic resonance imaging (MRI) to
establish any epileptic focus. Along with a question-
naire about the effect of epilepsy on various aspects
of the patient’s life, this was intended to establish
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the effect of anatomical and psychosocial factors
on the genesis of depressive illness in those with
epilepsy.
METHOD
Sample selection
All people attending at a specialist outpatient clinic
during a 6 months period were initially identified. Pa-
tients were excluded from the study for the following
reasons: age under 16 or over 65 years, not agree-
ing to take part in the study, no definite diagnosis
of epilepsy made, incomplete questionnaires returned,
referred from another secondary service or diagnosis
of learning disability previously made.
Information collected
Information was gathered from questionnaires com-
pleted by the patient sample, from study of the case
notes and, in some cases by examination by a psychia-
trist. The patient questionnaires comprised the follow-
ing: a series of Likert scales to identify the patient’s
subjective impression of the effect of epilepsy on their
life (covering work, relationships, side-effects of med-
ication, mobility and socialising), secondly a question-
naire to establish the patient’s perception of frequency
of attacks and past diagnosis or treatment of depressive
illness, and, finally, a hospital anxiety and depression
scale (HAD)8 for completion. If the HAD suggested
that the patient may have a depressive illness, then
they were offered an appointment with a psychiatrist
(G.B.) in order to establish whether this was truly the
case and if necessary offer appropriate treatment.
The information gathered from the case notes in-
cluded whether the patient had been diagnosed with,
or treated for, a depressive illness in the past, the type
of epilepsy diagnosed, when this diagnosis was first
made, current anti-epileptic medication, reported fit
frequency and the results of investigations to localise
a lesion.
Definition of depressive illness
Patients were identified by whether they were, or had
whilst having epilepsy, experienced a depressive ill-
ness. A depressive illness was taken to have been
present in the past if there was evidence in the case
notes that it had been diagnosed by a psychiatrist or
general practitioner. A current episode was taken as
been present if, in accordance with ICD 10, a diagno-
sis of moderate or severe depressive illness was made
by the psychiatrist (G.B.) (usually following comple-
tion of the HAD). The cut-off point for further assess-
ment after the HAD scale was taken as a score of 8.
Patients scoring 8 or more but declining interview by
the psychiatrist were excluded from the study as it has
been shown that whilst it is a sensitive instrument, the
HAD scale has poor positive predictive value9.
RESULTS
One hundred and thirty patients attending the epilepsy
clinic fulfilled the criteria for inclusion in the study.
Of these, 78 (60%) agreed to take part in the study
and fully completed the three questionnaires. Thirteen
agreed to take part but failed to fully complete the
questionnaires and thus, were excluded from the study.
Of these 15 (19%) of the full responders had a history
of depressive illness as described before and 16 (21%)
had a current episode identified by HAD scale and
clinical interview. A further four patients who scored
over 8 on the HAD scale had to be excluded from
the study as they declined an interview with the psy-
chiatrist which would have confirmed a diagnosis of
depressive illness. Between the two identified groups
(never experienced depressive illness and current or
history of depressive illness) there was no statistically
significant difference with regard to sex, age, employ-
ment, type of epilepsy or number of anti-epileptic
drugs being prescribed.
Within the questionnaire, patients were asked to
indicate to what extent having epilepsy affected their
lives in certain areas. This was done by use of a Likert
scale and the areas of life assessed were: fatigue, work
opportunity, mobility, social relationships, sexual rela-
tionships and general activity level. This should have
allowed a simple overall assessment of the degree to
which the patient felt handicapped by epilepsy. Of
these areas, the only ones to show a significant asso-
ciation with depressive illness using the chi-squared
test were an effect on mobility and an effect on gen-
eral activity (both P < 0.001) (see Table 1). When
this comparison was restricted to those currently di-
agnosed with a depressive illness, the difference was
Table 1: Statistically significant factors associated with
depressive illness in epilepsy
No depressive Presence or history
illness (n = 47) of depressive
illness (n = 31)
Right sided lesion 11 (23%) 13 (42%)
Diagnosed when adult 18 (38%) 12 (55%)
Greatly effects mobility 13 (28%) 14 (45%)
Greatly effects activity 14 (30%) 13 (42%)
Less than one attack
per month
18 (35%) 5 (16%)
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even more marked and a perceived marked effect
on the individual’s sexual and social relationships
were also found to be associated with depressive
illness.
Of the 78 patients involved in the study all had ei-
ther an EEG, CT scan or MRI with most having two
of these tests. This allowed comparisons to be made
between those patients having an identified focus and
those not. In all 34 (44%) had a focus identified and
this itself was linked with depressive illness (P <
0.001) as was the focus being present on the right
side (P < 0.001) (see Table 1)—thus, those with a
left sided lesion were less likely to have a depressive
episode than the group as a whole. Probably the most
robust finding of previous studies was an association
between an anatomical feature of epilepsy and depres-
sive illness is the presence of a temporal lobe focus2, 3.
However, not only did this study fail to demonstrate
such an association but also failed to show a trend to-
wards this finding.
Patients who had experienced a depressive episode
were more likely to have been diagnosed with epilepsy
in adulthood (>21 years) than those with no such his-
tory (55 vs. 38% significant for P < 0.001) and more
likely to be having one fit or more per month (16 vs.
35% significant for P < 0.001) (see Table 1). There
was also, not surprisingly, a trend for people with de-
pressive illness to be having more frequent attacks.
As there was a possibility of selective bias in the
sample from those declining to take part in the study,
the above-mentioned features were compared between
the group being studied and the group declining. Us-
ing the chi-squared test no statistically significant dif-
ference was found.
Discussion
The factors identified that could be seen to indicate
a psychosocial cause were diagnosis in adulthood,
having more than one or more attacks per month and
perceived marked reduction in mobility and general
activity due to having epilepsy. However, though
it is tempting to identify a causal effect which has
some prima facie validity, it must be remembered
that common symptoms of depressive illness itself
are social withdrawal and loss of interest in outside
activities. Thus, it may be that patients are simply
describing their symptoms of depression and wrongly
attributing them to epilepsy. It is, however, difficult
to argue that epilepsy does not have a large effect
on lifestyle in these areas. Driving is generally not
permitted unless epilepsy is well controlled and the
uncertainty of when the next attack may occur leads
many people with poorly controlled epilepsy to be
reluctant to leave familiar or safe environments. This
loss of opportunity and difficulty adjusting to it may
be one reason why those who also have a depressive
illness were found to have been more likely to have
been diagnosed in adulthood.
With regard to factors that would support an as-
sociation linked with brain structure or activity, the
findings in this study are at odds with the weight of
research thus far. It is generally considered that a left
sided locus rather than one on the right side, would be
associated with depressive illness. The reasons for this
difference are unclear. However, a few factors need to
be taken into account. Firstly, it has been established
that patients attending secondary care epilepsy cen-
tres have a lower incidence of depressive illness than
those attending more specialist centres10 and so, with
relatively smaller numbers statistical anomalies are
more likely to occur. In a similar vein, there is also the
suggestion that, compared with psychosocial factors,
the effect of an epileptic focus may be small5, again,
with the result of greater likelihood of statistical arte-
facts. Finally, it would clearly be unwise to forget
the 40% of clinic attendees who did not take part in
the study. Though there was no significant difference
in presence or laterality of focus when compared
with the responders, little can be said about the pres-
ence or otherwise of a depressive illness. Thus, when
looking for a potentially small effect, this could be
crucial.
Given that depressive illness is a relatively common
disorder (prevalence of 5–8% in the general popula-
tion), when looking for factors that lead to develop in
those with epilepsy, it is important to remember that
a significant proportion could have been expected to
develop the illness regardless of features of epilepsy.
Similarly, this study like many others has looked at
epilepsy as a whole. Given that depressive illness has a
complex aetiology it is likely that different factors are
relevant in different cases. For example, the learned
helplessness model7 may be more relevant in people
with more than one type of seizure (as this may re-
sult in less predictability of an attack) and, thus be a
factor in explaining the apparent increased incidence
of depression in this specific group11. By studying
the heterogeneous group of people with epilepsy as a
whole, it is possible that factors important for some
people in the aetiology of depressive illness are los-
ing significance when a larger, more diverse group is
studied.
LIMITATIONS
The multifactorial nature of depressive illness and the
varying relevance of such aetiological factors between
individuals has already been discussed. In order to
identify these with statistical significance requires
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large studies with detailed information. Though in
this study there was considerable clinical information
available, 52 people (40%) either declined to take part
in the study or were excluded as the questionnaires
were not fully completed. This represents a significant
loss of power for the study.
The reluctance of patients from the neurology outpa-
tient clinics to see psychiatrists has been commented
on already12 and clinical screening for depressive ill-
ness by a psychiatrist would be impractical and un-
acceptable to most patients. A screening tool must,
therefore, be used which cannot be 100% sensitive
and does not have the flexibility that a clinical assess-
ment does. For this study, the HAD was used as it
was designed for use in the medically unwell popula-
tion. It has been suggested that whilst the HAD is a
relatively sensitive instrument (80–100%) it has a low
positive predictive value9 and so should be used (as
in this case) as a screening instrument rather than one
for diagnosis. This identifies two possible sources of
error in this study: firstly four patients scoring above
the cut-off point of 8 and declining clinical interview
by the psychiatrist were excluded from the study, thus
a significant group was lost, and secondly there would
be up to 20% of people with depressive illness not
identified by the rating scale and, thus included in the
wrong group for comparison.
CONCLUSIONS
In this study, the only features of people with epilepsy
found to be statistically significantly associated with
the presence of a depressive illness were: a right sided
focus/lesion, diagnosis in adulthood, a perception that
having epilepsy severely affects mobility or general
activity and having one or more attacks each month.
Many of these findings are not in accordance with
previous studies investigating the problem, though es-
tablishing robust anatomical associations between the
two disorders has been difficult and this study, to some
extent adds further to the uncertainty. It is interest-
ing, however, that both anatomical and psychosocial
variables have shown significant associations which
would support a multifactorial model.
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